Nanoengineering has emerged as a groundbreaking discipline within the pharmaceutical field, revolutionizing drug delivery and therapeutic interventions. At the intersection of nanotechnology and pharmaceuticals, nanoengineering involves the design, manipulation, and application of materials at the nanoscale to enhance drug efficacy and minimize adverse effects. By exploiting the unique properties exhibited by materials at the nanoscale, such as increased surface area and improved bioavailability, nanoengineering enables precise control over drug release kinetics and targeted delivery to specific cells or tissues.
This approach holds tremendous promise for addressing challenges associated with traditional drug formulations, including poor solubility and systemic toxicity. Nanoengineered pharmaceuticals, often in the form of nanoparticles or liposomes, can traverse biological barriers more effectively, allowing for enhanced therapeutic outcomes. Moreover, the ability to incorporate imaging agents into these nanostructures facilitates real-time monitoring of drug distribution within the body. As nanoengineering continues to evolve, it offers unparalleled opportunities to optimize drug design, improve patient compliance, and usher in a new era of personalized medicine in the pharmaceutical landscape.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico